NCT04464070View on ClinicalTrials.gov

Pathways of Eicosanoid Metabolism

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions

Metabolism of Prostaglandin D2

Interventions

DIETARY_SUPPLEMENT

niacin

induce biosynthesis of PGD2

DRUG

aspirin

inhibition of cyclooxygenase

OTHER

PGD2

labeled precursor

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors

collaborator

Vanderbilt University Medical Center

OTHER

lead

Vanderbilt University

OTHER